Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Raymond James Financial, Inc. currently has a C$1.40 target

<< Previous

Bullboard Posts

Next >>

Post by CBalardoon Feb 05, 2017 12:15pm

262 Views

Post# 25801702

Raymond James Financial, Inc. currently has a C$1.40 target

Seems like a good stock well diversified 80 % is US because of that we should have already had at least a 20 % lift due to currency value. My target is $3.00 by this time next year

<< Previous

Bullboard Posts

Next >>

BlackBerry’s cost-cutting yields Q1 2024 savings